Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Down 5.6% in April

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the target of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 3,520,000 shares, a decrease of 5.6% from the March 31st total of 3,730,000 shares. Approximately 3.9% of the shares of the stock are short sold. Based on an average trading volume of 566,600 shares, the short-interest ratio is presently 6.2 days.

Insider Buying and Selling

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Avidity Partners Management LP raised its position in shares of Acadia Healthcare by 61.8% during the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after buying an additional 441,692 shares during the last quarter. Sea Cliff Partners Management LP acquired a new position in shares of Acadia Healthcare during the fourth quarter valued at about $26,338,000. Vaughan Nelson Investment Management L.P. acquired a new position in shares of Acadia Healthcare during the fourth quarter valued at about $24,157,000. OFI Invest Asset Management raised its position in shares of Acadia Healthcare by 290.5% during the third quarter. OFI Invest Asset Management now owns 331,129 shares of the company’s stock valued at $21,990,000 after buying an additional 246,322 shares during the last quarter. Finally, Jennison Associates LLC increased its stake in Acadia Healthcare by 26.1% in the fourth quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock valued at $89,327,000 after acquiring an additional 238,114 shares during the period.

Wall Street Analyst Weigh In

Several research analysts have commented on ACHC shares. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research report on Monday, March 4th. Barclays assumed coverage on Acadia Healthcare in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 target price for the company. TD Cowen lifted their target price on Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. Mizuho lifted their target price on Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a research note on Wednesday, March 6th. Finally, TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.00.

Acadia Healthcare Trading Up 1.4 %

Acadia Healthcare stock opened at $74.61 on Tuesday. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a 12 month low of $66.49 and a 12 month high of $87.77. The company’s fifty day simple moving average is $77.91 and its 200-day simple moving average is $77.73. The stock has a market cap of $6.90 billion, a P/E ratio of -298.43, a P/E/G ratio of 2.17 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. The business had revenue of $742.80 million during the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. Acadia Healthcare’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.70 EPS. As a group, sell-side analysts forecast that Acadia Healthcare will post 3.57 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.